COVID-19: FDA Issues Emergency Use Authorization for Hemolung RAS
ALung is committed to the safety and support of health care professionals, patients, and employees in the treatment of COVID-19. The following represents ALung’s commitment to supporting FDA’s response to the COVID-19 pandemic in the United States.
Training & Support (US)
24×7 Clinical/Technical Support
For clinical/technical support, medical affairs, or protocol questions, please email: Hemolung_EUA@alung.com
For all other inquires, please call our main office at:
The following instructional and training materials are available to US clinical trial sites:
- Instructions for use
- Quick reference guides
- Training videos
Please contact an ALung representative to access to these materials.